Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group
Published in
Journal of acquired immune deficiency syndromes and human retrovirology, vol. 17, no. 3, p. 239-244Publication date
1998Abstract
Keywords
- Adult
- Anti-HIV Agents/ therapeutic use
- CD4 Lymphocyte Count
- Cohort Studies
- Didanosine/therapeutic use
- Dideoxynucleosides/ therapeutic use
- Disease Progression
- Drug Therapy, Combination
- Europe
- Female
- Follow-Up Studies
- HIV Infections/ drug therapy/mortality
- Humans
- Lamivudine/therapeutic use
- Male
- Middle Aged
- Proportional Hazards Models
- Prospective Studies
- Stavudine/therapeutic use
- Survival Analysis
- Zalcitabine/therapeutic use
- Zidovudine/ therapeutic use
UNIGE affiliation entities
Citation (ISO format)
PHILLIPS, A. N. et al. Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group. In: Journal of acquired immune deficiency syndromes and human retrovirology, 1998, vol. 17, n° 3, p. 239–244. doi: 10.1097/00042560-199803010-00009
Identifiers
- PID : unige:9415
- DOI : 10.1097/00042560-199803010-00009
- PMID : 9495224
